ADMA Biologics
ADMA
ADMA
24 hedge funds and large institutions have $65.1M invested in ADMA Biologics in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $68.1M → $65.1M (-$3.01M)
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$446K | |
| 2 | +$342K | |
| 3 | +$128K | |
| 4 |
PCM
Prelude Capital Management
New York
|
+$68.7K |
| 5 |
TI
Telemetry Investments
New York
|
+$33.2K |
Top Sellers
| 1 | -$294K | |
| 2 | -$42.6K | |
| 3 | -$23.9K | |
| 4 |
Goldman Sachs
New York
|
-$22.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.01K |